Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) will report its second quarter 2026 financial results on Monday, August 3, 2026, before the U.S. market opens. Management will host a conference call and webcast at 8:30 a.m. ET that day. A live webcast will be available online, with a replay accessible for at least 30 days via the Investors section of the company’s website.

News Market Reaction – KRYS

+2.35% 9.9x vol

1 alert

+2.35% Session close to close

$9.93B Market Cap

9.9x Rel. Volume

In the Jul 24 session, KRYS gained 2.35%, reflecting a moderate positive market reaction. Trading volume was exceptionally heavy at 9.9x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Market Context

KRYS had Net Selling across the 90-day insider window, adding platform context to this scheduling no...

Analysis

KRYS had Net Selling across the 90-day insider window, adding platform context to this scheduling notice. The August 3 release is the next checkpoint; investors can watch the financial results and business update, with insider activity a risk factor.

Key Figures

Reporting period: Q2 2026 Reporting date: August 3, 2026 Conference call time: 8:30 am ET +1 more

4 metrics

Reporting period Q2 2026 Financial results scheduled for August 3, 2026

Reporting date August 3, 2026 Results scheduled prior to the open of U.S. markets

Conference call time 8:30 am ET August 3, 2026 financial-results webcast and business update

Replay availability At least 30 days Replay available on the Investors section of the company website

Previous Earnings date Reports

2 past events · Latest: Apr 21 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 21	Earnings date	Neutral	-1.4%	Scheduled first-quarter results and an 8:30 AM ET management webcast
Feb 10	Earnings date	Neutral	-0.7%	Scheduled fourth-quarter and full-year results before market open

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two prior earnings-date announcements were followed by negative 24-hour moves, averaging -1.04%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, July 23, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its second quarter 2026 financial results on Monday, August 3, 2026, prior to the open of U.S. markets.

The Company’s management will also host a conference call and webcast at 8:30 am ET on Monday, August 3, 2026, to discuss the financial results and provide a business update.

Investors and the general public can access the live webcast at: https://www.webcaster5.com/Webcast/Page/3018/54300.

For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company’s website at www.krystalbio.com.

About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. Visit www.krystalbio.com to learn more or follow us on LinkedIn and X.

CONTACT
Investors and Media:                                                             
Stéphane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com                                    

FAQ

When will Krystal Biotech (KRYS) report its Q2 2026 earnings?

Krystal Biotech will report its second quarter 2026 financial results on Monday, August 3, 2026, before U.S. markets open. According to Krystal Biotech, this release will be accompanied by a management conference call and webcast later that morning.

What time is Krystal Biotech's Q2 2026 earnings conference call on August 3, 2026?

Krystal Biotech’s Q2 2026 earnings conference call and webcast are scheduled for 8:30 a.m. Eastern Time on August 3, 2026. According to Krystal Biotech, management will discuss quarterly financial results and provide a business update during the call.

How can investors access the Krystal Biotech (KRYS) Q2 2026 earnings webcast?

Investors can access the live Q2 2026 webcast at https://www.webcaster5.com/Webcast/Page/3018/54300. According to Krystal Biotech, this link will stream management’s discussion of financial results and business updates on August 3, 2026.

Will a replay be available for Krystal Biotech's Q2 2026 earnings call?

Yes, a replay of Krystal Biotech’s Q2 2026 earnings webcast will be available for at least 30 days. According to Krystal Biotech, the replay can be accessed through the Investors section of its website at www.krystalbio.com.

Where can I find investor information for Krystal Biotech around the Q2 2026 results date?

Investor information, including the Q2 2026 webcast replay, will be available on Krystal Biotech’s Investors webpage at www.krystalbio.com. According to Krystal Biotech, the earnings call replay will remain accessible there for at least 30 days.